Last update 08 May 2025

KATP channels x SUR x DPP-4

Basic Info

Related Targets
KATP channelsSURDPP-4

Related

1
Drugs associated with KATP channels x SUR x DPP-4
Gemigliptin L-tartrate Sesquihydrate/Glimepiride
Target
DPP-4 x KATP channels x SUR
Mechanism
DPP-4 inhibitors [+2]
Active Org.-
Originator Org.
LG Life Sciences Ltd.LG Life Sciences Ltd.
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 2
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with KATP channels x SUR x DPP-4
NCT02089126
/ Unknown statusPhase 3
A Multicenter, Randomized, Placebo-controlled, Parallel Group, Double-blind, Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride Alone
100 Clinical Results associated with KATP channels x SUR x DPP-4
Login to view more data
100 Translational Medicine associated with KATP channels x SUR x DPP-4
Login to view more data
0 Patents (Medical) associated with KATP channels x SUR x DPP-4
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free